Johnson & Johnson (JNJ)
US market · Health Technology
Johnson & Johnson stock (JNJ) is compliant with AAOIFI Shari'ah Standard No. 21 per our screen dated 2026-10-27: debt 8% and cash 3% of the 12-month average market capitalisation against a 30% limit.
- Price
- 266.30 USDLast close 2026-10-26
- Market cap
- 641.07 B USDat the 2026-10-26 close
- Symbol
- NYSE:JNJ
- Market
- US market
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
What the company does: U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer (source: Wikidata)
Figures as of 2026-10-27 01:58
Sharia screening
Compliant under the screens we ran
We apply AAOIFI Shari'ah Standard No. 21, Financial Paper (Shares and Bonds), issued on 30 Rabi' I 1425 AH (20 May 2004), as published on AAOIFI's website. We last reviewed its limits on 2026-10-01. We read what the standard says; we do not issue fatwas.
This is an automated read of published screens, not a fatwa. We name what we ran; whatever we did not run stays outside the read.
Johnson & Johnson in numbers
Johnson & Johnson ranks 2 of 391 in the Health Technology sector on US market by market cap (641.07 B USD). Its debt-to-equity ratio is 0.55. Dividends have been paid 46 years running. The P/E is 40.4. The annual dividend yield is 2%.
Published figures with their date, not financial advice. Market cap, P/E and dividend yield use the 2026-10-26 close.
The five screens, one by one
87 / 100 · Compliant, wide margin from the limits · Not applied: receivables · as of 2026-10-27
87 / 100 · Compliant, wide margin from the limits · Not applied: receivables · as of 2026-10-27
We ran 4 of 5 screens; the score is 87 out of 100.
| Business activity (sector and industry) | No excluded activity in its sector or industry | Passed |
| Interest-bearing debt to market cap | 8%, limit 30% | Passed |
| Cash and interest-bearing securities to market cap | 3%, limit 30% | Passed |
| Non-permissible income to revenue | 1.1%, limit 5% | Passed |
| Receivables to market cap | Not run: the standard sets no limit for it |
Purification share
We do not publish a per-share purification amount yet. The non-permissible income share appears on the 5% line when we measure it, and when we do not, we do not guess a figure.
Figures as of 2026-10-27 01:58
Company facts
- Debt-to-equity ratio 0.55
- Consecutive years paying a dividend 46 years
- Share of profits paid out 80.1%
Figures computed from the company's published financial statements and read on 2026-10-27. They move with every new statement; this states a figure, it is an educational reading, not financial advice.
Fundamental filter
Solid fundamentals
- The company actually earned a profit over the last twelve months. Met
- Its debt does not exceed twice its shareholders' equity. Met
- The rest of the fundamental filter: every check in full, with its state — met, not met, or not measured.
- And whatever the source does not publish is named as such — never counted as a met check.
These are this page's items only; each plan's full list is on the pricing page.
Figures as of 2026-10-27
An automated quality screen on published figures, not financial advice. Every threshold is stated, every reason is named with its figure and its date, and the decision stays yours.
Today's model reading
The same four tools that read the daily report's markets, applied to this stock's completed bars.
- Today's call on this stock — up, down, or no call — and how many model votes stand behind it.
- All four tools one by one: cycles, historical analogue, seasonal pattern and momentum — each with its lean and its figure, and any tool that gave no read is named as such.
- Last completed close, average daily range, twenty-day range and the month band — shown when this stock has enough bars to compute them.
These are this page's items only; each plan's full list is on the pricing page.
Completed bars through 2026-10-26 · 10035 bars
Automated educational reading, not a recommendation. The decision is yours.
Frequently asked about Johnson & Johnson
What is the sharia compliance score of Johnson & Johnson?
Johnson & Johnson: 87 / 100 · Compliant, wide margin from the limits · Not applied: receivables · as of 2026-10-27. The score out of 100 measures how far the debt and cash ratios sit from their stated limits; the five screens are broken down on this page.
Does Johnson & Johnson stock need purification?
We do not publish a per-share purification amount yet. The non-permissible income share appears on the 5% line when we measure it, and when we do not, we do not guess a figure.
Does Johnson & Johnson pay dividends?
The company has paid dividends 46 years running, a payout of 80.1% of earnings, an annual dividend yield of 2% at the 2026-10-26 close. Published figures with their date, not a recommendation.
How do I work out zakat on Johnson & Johnson shares?
The zakat calculator on this site gives an indicative amount from the value of the shares you hold; detailed rulings belong to scholars.
Which market lists Johnson & Johnson?
Johnson & Johnson is listed on US market under the symbol JNJ.
Latest news on the company
- Johnson & Johnson Reveals Striking Cancer Trial ResultsGuruFocus ·
- J&J reports 75% tumor response rate with novel prostate cancer therapySeeking Alpha ·
- Bayer Gets China Approval for Stroke-Prevention Drug in Global First for New Class — UpdateDow Jones Newswires ·
- Weekly Recap: JNJ Q2026 EPS drop and JNJ-6143 Phase 1 responseTradingView ·
- Johnson & Johnson reports response rate for head, neck cancer treatmentSeeking Alpha ·
News from its original sources; the reading is in your account.
What the subscription adds
This page is open to everyone. Inside the subscription this stock also carries its composite score and its parts, valuation ratios, its share of its sector, a read of its financial statements, and following it from your account. None of them is financial advice.